Format

Send to

Choose Destination
Ann Rheum Dis. 2019 Mar 23. pii: annrheumdis-2019-215187. doi: 10.1136/annrheumdis-2019-215187. [Epub ahead of print]

Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial.

Author information

1
Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
2
Division of Medical Statistics, Medical Research Collaborating Center, Seoul National University College of medicine, Seoul, Republic of Korea.
3
Division of Infectious Diseases, Oregon Health and Science University, Portland, Oregon, USA.
4
Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea leb7616@snu.ac.kr.

KEYWORDS:

discontinuation; influenza; methotrexate; rheumatoid arthritis; vaccination

Conflict of interest statement

Competing interests: EBL has acted as a consultant to Pfizer and has received research grants from GC Pharma and Hanmi Pharm.

Publication type

Publication type

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center